These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24350886)

  • 1. Optimising outcome assessment to improve quality and efficiency of stroke trials.
    McArthur K; Fan Y; Pei Z; Quinn T
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):101-11. PubMed ID: 24350886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials.
    Uyttenboogaart M; Stewart RE; Vroomen PC; De Keyser J; Luijckx GJ
    Stroke; 2005 Sep; 36(9):1984-7. PubMed ID: 16081854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials.
    Quinn TJ; Lees KR; Hardemark HG; Dawson J; Walters MR
    Stroke; 2007 Aug; 38(8):2257-61. PubMed ID: 17600236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical interpretation and use of stroke scales.
    Kasner SE
    Lancet Neurol; 2006 Jul; 5(7):603-12. PubMed ID: 16781990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents.
    Cramer SC; Koroshetz WJ; Finklestein SP
    Stroke; 2007 Apr; 38(4):1393-5. PubMed ID: 17332455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.
    Hallevi H; Albright KC; Martin-Schild SB; Barreto AD; Morales MM; Bornstein N; Ifejika NL; Shuaib A; Grotta JC; Savitz SI;
    Cerebrovasc Dis; 2009; 28(4):341-8. PubMed ID: 19628935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese medicine NeuroAiD efficacy stroke recovery-extension study (CHIMES-E study): an observational multicenter study to investigate the longer-term efficacy of NeuroAiD in stroke recovery.
    Venketasubramanian N; Young S; Tay SS; Chang HM; Umapathi T; Chan B; de Silva A; Wong L; Navarro J; Zhao YD; Tan SB; Chen C
    Cerebrovasc Dis; 2013; 35 Suppl 1():18-22. PubMed ID: 23548915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level.
    Ovbiagele B; Saver JL
    Cerebrovasc Dis; 2010; 29(1):50-6. PubMed ID: 19893312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
    Steeves JD; Lammertse D; Curt A; Fawcett JW; Tuszynski MH; Ditunno JF; Ellaway PH; Fehlings MG; Guest JD; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Short D; Nakamura M; Coleman WP; Gaviria M; Privat A;
    Spinal Cord; 2007 Mar; 45(3):206-21. PubMed ID: 17179972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.
    Saver JL
    Stroke; 2007 Nov; 38(11):3055-62. PubMed ID: 17916765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.
    Savitz SI; Benatar M; Saver JL; Fisher M
    Cerebrovasc Dis; 2008; 26(2):156-62. PubMed ID: 18560219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the modified Rankin Scale: a systematic review.
    Quinn TJ; Dawson J; Walters MR; Lees KR
    Stroke; 2009 Oct; 40(10):3393-5. PubMed ID: 19679846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale.
    Chaisinanunkul N; Adeoye O; Lewis RJ; Grotta JC; Broderick J; Jovin TG; Nogueira RG; Elm JJ; Graves T; Berry S; Lees KR; Barreto AD; Saver JL; ;
    Stroke; 2015 Aug; 46(8):2238-43. PubMed ID: 26138130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the reliability of the modified rankin scale.
    Quinn TJ; Dawson J; Walters MR; Lees KR
    Stroke; 2009 Mar; 40(3):762-6. PubMed ID: 19131664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
    D'Souza M; Kappos L; Czaplinski A
    J Neurol Sci; 2008 Nov; 274(1-2):76-9. PubMed ID: 18817932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?
    Weisscher N; Vermeulen M; Roos YB; de Haan RJ
    J Neurol; 2008 Jun; 255(6):867-74. PubMed ID: 18338195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome 3 months after stroke predicts long-term survival.
    Eriksson M; Norrving B; Terént A; Stegmayr B
    Cerebrovasc Dis; 2008; 25(5):423-9. PubMed ID: 18349536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.
    Banks JL; Marotta CA
    Stroke; 2007 Mar; 38(3):1091-6. PubMed ID: 17272767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need to clarify Thrombolysis In Myocardial Ischemia (TIMI) scale scoring method in the Penumbra Pivotal Stroke Trial.
    Saver JL; Liebeskind DS; Nogueira RG; Jahan R
    Stroke; 2010 Feb; 41(2):e115-6. PubMed ID: 20035075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.